Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Condition:   Non-small Cell Lung CancerInterventions:   Drug: eribulin mesylate + erlotinib;   Drug: eribulin mesylate + erlotinibSponsor:   Eisai Inc.Recruiting - verified May 2010